Jiangang Liu

机构：Eli Lilly (United States) · ORCID：0000-0002-2800-077X

发表论文 303 篇 · 总被引 4089 次 · h-index 18

代表论文

• Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis (2024 · EClinicalMedicine · 被引 61)
• Morusin regulates the migration of M2 macrophages and GBM cells through the CCL4-CCR5 axis (2024 · International Immunopharmacology · 被引 3)
• Characterization of dynamic interplay among different channels during immiscible displacement in porous media under different flow rates (2024 · The European Physical Journal E · 被引 2)
• Survival benefit from abemaciclib in non–small cell lung cancer by Kirsten rat sarcoma–mutation gene expression subtype: retrospective analysis from the JUNIPER Trial (2025 · Frontiers in Oncology · 被引 1)
• Zedoarondiol Inhibits Neovascularization in Atherosclerotic Plaques of ApoE−/− Mice by Reducing Platelet Exosomes-Derived MiR-let-7a (2024 · Chinese Journal of Integrative Medicine · 被引 1)
• Table S3 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma (2025)